Motivated by our recent finding that 4'-ethynylstavudine (
4) is a promising anti-human immunodeficiencyvirus type 1 (HIV-1) agent, we synthesized its 4'-thio analogue, as well as other 4'-thiostavudines having acarbon substituent at the 4'-position, as racemates in this study. Methyl 3-oxo-tetrahydrothiophen-2-carboxylate(
5) was used as a starting material to construct the requisite 4-thiofuranoid glycal (
13). Introduction of athymine base was carried out by an electrophilic addition reaction to
13 using
N-iodosuccinimide (NIS) andbis(trimethylsilyl)thymine. The desired
-anomer (
16) obtained as a major product in this reaction underwentready elimination with activated Zn to give the 4'-carbomethoxy derivative (
18). By using
18 as a commonintermediate, 4'-carbon-substituted (CH
2OH, CO
2Me, CONH
2, CH=CH
2, CN, and C
CH) 4'-thiostavudineswere prepared. Among these six compounds, 4'-cyano (
28) and 4'-ethynyl (
29) analogues were found toshow inhibitory activity against HIV-1 with ED
50 values of 7.6 and 0.74
M, respectively. The activity of
29 was comparable to that of stavudine, but
29 was not as active as
4. Optical resolution of
29 was brieflyexamined.